Have your own idea? Try our Stock Screener
Canadian (TSX) Drug Retail Industry Analysis
UpdatedAug 21, 2026
DataAggregated Company Financials
Companies4
- 7D-1.0%
- 3M-6.9%
- 1Y13.7%
- YTDn/a
The Drug Retail is pretty flat in the last 7 days, but TelyRx Holdings has stood out, gaining 10.0%. The past year has been better, since the industry has gained 13% in that time. As for the next few years, earnings are forecast to decline by 4.3% per annum.
Industry Valuation and Performance
Has the Canadian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 21 Aug 2026 | CA$478.7m | CA$532.3m | CA$8.7m | 20.3x | 55.1x | 0.9x |
| Sun, 19 Jul 2026 | CA$662.3m | CA$512.9m | CA$13.1m | 19.5x | 50.4x | 1.3x |
| Tue, 16 Jun 2026 | CA$460.3m | CA$512.8m | CA$13.1m | 20.9x | 35x | 0.9x |
| Thu, 14 May 2026 | CA$361.7m | CA$431.3m | CA$27.2m | 21.3x | 13.3x | 0.8x |
| Sat, 11 Apr 2026 | CA$346.4m | CA$421.3m | CA$27.1m | 56.7x | 12.8x | 0.8x |
| Mon, 09 Mar 2026 | CA$350.2m | CA$421.3m | CA$27.1m | 57.1x | 12.9x | 0.8x |
| Wed, 04 Feb 2026 | CA$362.8m | CA$417.4m | CA$1.1m | 396.1x | 327.2x | 0.9x |
| Fri, 02 Jan 2026 | CA$361.1m | CA$417.4m | CA$1.1m | 400.5x | 325.6x | 0.9x |
| Sun, 30 Nov 2025 | CA$334.1m | CA$417.4m | CA$1.1m | 360.9x | 301.3x | 0.8x |
| Tue, 28 Oct 2025 | CA$334.1m | CA$410.9m | -CA$1,394,243.00 | 55.3x | -239.6x | 0.8x |
| Thu, 25 Sep 2025 | CA$320.9m | CA$410.9m | -CA$1,394,243.00 | 56.6x | -230.1x | 0.8x |
| Sat, 23 Aug 2025 | CA$277.4m | CA$408.6m | -CA$1,567,926.00 | 62.1x | -176.9x | 0.7x |
| Mon, 21 Jul 2025 | CA$270.2m | CA$405.0m | -CA$3,719,599.00 | 58.1x | -72.6x | 0.7x |
| Wed, 18 Jun 2025 | CA$284.1m | CA$405.0m | -CA$3,719,599.00 | 61.5x | -76.4x | 0.7x |
| Fri, 16 May 2025 | CA$225.8m | CA$372.3m | -CA$4,769,825.00 | n/a | -47.3x | 0.6x |
| Sun, 13 Apr 2025 | CA$218.2m | CA$368.1m | -CA$6,489,338.00 | n/a | -33.6x | 0.6x |
| Tue, 11 Mar 2025 | CA$215.8m | CA$368.1m | -CA$6,489,338.00 | n/a | -33.3x | 0.6x |
| Thu, 06 Feb 2025 | CA$200.3m | CA$367.0m | -CA$7,944,338.00 | n/a | -25.2x | 0.5x |
| Sat, 04 Jan 2025 | CA$179.3m | CA$367.0m | -CA$7,944,338.00 | n/a | -22.6x | 0.5x |
| Mon, 02 Dec 2024 | CA$183.7m | CA$367.0m | -CA$7,944,338.00 | n/a | -23.1x | 0.5x |
| Wed, 30 Oct 2024 | CA$201.5m | CA$366.8m | -CA$8,148,267.00 | n/a | -24.7x | 0.5x |
| Fri, 27 Sep 2024 | CA$192.5m | CA$366.8m | -CA$8,148,267.00 | n/a | -23.6x | 0.5x |
| Sun, 25 Aug 2024 | CA$168.9m | CA$366.6m | -CA$7,621,633.00 | n/a | -22.2x | 0.5x |
| Tue, 23 Jul 2024 | CA$140.7m | CA$369.1m | -CA$3,773,000.00 | n/a | -37.3x | 0.4x |
| Thu, 20 Jun 2024 | CA$138.3m | CA$369.1m | -CA$3,773,000.00 | n/a | -36.6x | 0.4x |
| Sat, 18 May 2024 | CA$127.5m | CA$369.1m | -CA$3,773,000.00 | n/a | -33.8x | 0.3x |
| Mon, 15 Apr 2024 | CA$119.2m | CA$370.7m | -CA$5,405,000.00 | n/a | -22.1x | 0.3x |
| Wed, 13 Mar 2024 | CA$946.9m | CA$1.2b | -CA$38,106,000.00 | n/a | -24.8x | 0.8x |
| Fri, 09 Feb 2024 | CA$913.8m | CA$1.2b | -CA$43,234,000.00 | n/a | -21.1x | 0.7x |
| Sun, 07 Jan 2024 | CA$828.7m | CA$1.2b | -CA$43,234,000.00 | n/a | -19.2x | 0.7x |
| Tue, 05 Dec 2023 | CA$881.8m | CA$1.2b | -CA$32,998,000.00 | n/a | -26.7x | 0.7x |
| Thu, 02 Nov 2023 | CA$882.4m | CA$1.2b | -CA$33,343,000.00 | n/a | -26.5x | 0.7x |
| Sat, 30 Sep 2023 | CA$676.0m | CA$1.2b | -CA$33,343,000.00 | n/a | -20.3x | 0.6x |
| Mon, 28 Aug 2023 | CA$826.0m | CA$1.2b | -CA$33,343,000.00 | n/a | -24.8x | 0.7x |
Price to Earnings Ratio
-24.8x
Current Industry PE
- Investors are optimistic on the Canadian Drug Retail industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 54.6x which is higher than its 3-year average PE of 7.5x.
- The industry is trading close to its 3-year average PS ratio of 0.67x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years and the industry is now profitable.
- Revenues have declined 24% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, profits have been increasing.
Industry Comparison
How does Canadian Drug Retail compare with similar industries?
| CA Market | -1.11% | |
| Consumer Staples | -3.89% | |
| Food and Staples Retail | -4.16% | |
| Drug Retail | -0.96% | |
| Big Box Super Stores | 4.55% | |
| Food Retail | -4.17% | |
| Food Distributors | -4.40% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| TELY TelyRx Holdings | CA$2.70 | 3.8% +CA$4.9m | n/a | PS1.4x | |
| PCRX PharmaCorp Rx | CA$0.50 | 1.0% +CA$870.4k | 3.1% | PS3.2x |